BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lopes C, Tang Y, Anjo SI, Manadas B, Onofre I, de Almeida LP, Daley GQ, Schlaeger TM, Rego ACC. Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting. Front Cell Dev Biol 2020;8:576592. [PMID: 33072759 DOI: 10.3389/fcell.2020.576592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Lopes C, Ferreira IL, Maranga C, Beatriz M, Mota SI, Sereno J, Castelhano J, Abrunhosa A, Oliveira F, De Rosa M, Hayden M, Laço MN, Januário C, Castelo Branco M, Rego AC. Mitochondrial and redox modifications in early stages of Huntington's disease. Redox Biol 2022;56:102424. [PMID: 35988447 DOI: 10.1016/j.redox.2022.102424] [Reference Citation Analysis]
2 De Plano LM, Calabrese G, Conoci S, Guglielmino SPP, Oddo S, Caccamo A. Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders. Int J Mol Sci 2022;23:8714. [PMID: 35955847 DOI: 10.3390/ijms23158714] [Reference Citation Analysis]
3 Deus CM, Tavares H, Beatriz M, Mota S, Lopes C. Mitochondrial Damage-Associated Molecular Patterns Content in Extracellular Vesicles Promotes Early Inflammation in Neurodegenerative Disorders. Cells 2022;11:2364. [DOI: 10.3390/cells11152364] [Reference Citation Analysis]
4 Qin Y, Li S, Li XJ, Yang S. CRISPR-Based Genome-Editing Tools for Huntington's Disease Research and Therapy. Neurosci Bull 2022. [PMID: 35608753 DOI: 10.1007/s12264-022-00880-3] [Reference Citation Analysis]
5 Burtscher J, Romani M, Bernardo G, Popa T, Ziviani E, Hummel FC, Sorrentino V, Millet GP. Boosting mitochondrial health to counteract neurodegeneration. Progress in Neurobiology 2022. [DOI: 10.1016/j.pneurobio.2022.102289] [Reference Citation Analysis]
6 Kim C, Yousefian-Jazi A, Choi SH, Chang I, Lee J, Ryu H. Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease. Int J Mol Sci 2021;22:12499. [PMID: 34830381 DOI: 10.3390/ijms222212499] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Jadiya P, Garbincius JF, Elrod JW. Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling. Acta Neuropathol Commun 2021;9:124. [PMID: 34233766 DOI: 10.1186/s40478-021-01224-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
8 Monk R, Connor B. Cell Reprogramming to Model Huntington's Disease: A Comprehensive Review. Cells 2021;10:1565. [PMID: 34206228 DOI: 10.3390/cells10071565] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Beatriz M, Vilaça R, Lopes C. Exosomes: Innocent Bystanders or Critical Culprits in Neurodegenerative Diseases. Front Cell Dev Biol 2021;9:635104. [PMID: 34055771 DOI: 10.3389/fcell.2021.635104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
10 Behl T, Kaur G, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Zengin G, Bungau SG, Munteanu MA, Brisc MC, Andronie-Cioara FL, Brisc C. Elucidating the Multi-Targeted Role of Nutraceuticals: A Complementary Therapy to Starve Neurodegenerative Diseases. Int J Mol Sci 2021;22:4045. [PMID: 33919895 DOI: 10.3390/ijms22084045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]